Gene · 50652
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. | Int J Mol Sci | 2024 | 39337566 | PubTator, text mining | PubMed |
| UPCARE: Urinary Extracellular Vesicles-Derived Prostate Cancer Assessment for Risk Evaluation. | J Extracell Vesicles | 2024 | 39175282 | PubTator, text mining | PubMed |
| Simultaneous noninvasive ultrasensitive detection of prostate specific antigen and lncRNA PCA3 using multiplexed dual optical microfibers with strong plasmonic nanointerfaces. | Biosens Bioelectron | 2024 | 39151263 | PubTator, text mining | PubMed |
| Transcript Markers from Urinary Extracellular Vesicles for Predicting Risk Reclassification of Prostate Cancer Patients on Active Surveillance. | Cancers (Basel) | 2024 | 39001515 | PubTator, text mining | PubMed |
| Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer. | Front Pharmacol | 2024 | 38957390 | PubTator, text mining | PubMed |
| Re: Use of TP4303 to identify prostate cancer cells in voided urine samples. | Can J Urol | 2024 | 38912943 | PubTator, text mining | PubMed |
| Rho GTPase activating protein 21-mediated regulation of prostate cancer associated 3 gene in prostate cancer cell. | Braz J Med Biol Res | 2024 | 38896642 | PubTator, text mining | PubMed |
| Designing a Simple Electrochemical Genosensor for the Detection of Urinary PCA3, a Prostate Cancer Biomarker. | Micromachines (Basel) | 2024 | 38793175 | PubTator, text mining | PubMed |
| Deregulated Long Non-Coding RNAs (lncRNA) as Promising Biomarkers in Hidradenitis Suppurativa. | J Clin Med | 2024 | 38792557 | PubTator, text mining | PubMed |
| Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38761210 | PubTator, text mining | PubMed |
| Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer. | Cancers (Basel) | 2024 | 38730670 | PubTator, text mining | PubMed |
| The Lancet Commission on prostate cancer: planning for the surge in cases. | Lancet | 2024 | 38583453 | PubTator, text mining | PubMed |
| Predictive Value of Combined Detection of Serum PSA, PCA3, and Apparent Diffusion Coefficient of Magnetic Resonance Imaging in Bone Metastasis of Prostate Cancer. | Altern Ther Health Med | 2024 | 38401099 | PubTator, text mining | PubMed |
| A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53. | Int J Mol Sci | 2024 | 38256221 | PubTator, text mining | PubMed |
| How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update. | Cancers (Basel) | 2024 | 38254807 | PubTator, text mining | PubMed |
| Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. | Cancer Lett | 2024 | 38244911 | PubTator, text mining | PubMed |
| The role of ADAR1 through and beyond its editing activity in cancer. | Cell Commun Signal | 2024 | 38233935 | PubTator, text mining | PubMed |
| Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3. | J Cancer | 2024 | 38213719 | PubTator, text mining | PubMed |
| Association between platelet‑to‑lymphocyte ratio and serum prostate specific antigen. | Mol Clin Oncol | 2024 | 38213661 | PubTator, text mining | PubMed |
| Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer. | Clin Epigenetics | 2024 | 38173042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50652/papers?page=5